[…] “consistent” reductions in DUX4 activity along with improvements in strength and function by June Kinoshita, FSHD Society Avidity Biosciences, Inc., a San Diego-based biopharmaceutical company, announced this Wednesday, June 12, […]
Avidity shares interim data from its FORTITUDE trial
The FSH Society Issues Research Grant
[…] can evaluate electrical impedance myography (EIM) as a tool for quantifying the muscle structure of FSHD patients. Today, the FSH Society, a Massachusetts based non-profit that is a world leader in […]
FSH Society’s International Meeting to Bring Together Patients & Researchers From Around the World to Explore New Insights on Rare Disease
[…] charitable foundation that has transformed the science of a little-known disease, facioscapulohumeral muscular dystrophy ( FSHD), today announced its Biennial International Network Meeting. The meeting will be the one of […]
FSH Society Awards $541,133 in Funding for FSH Muscular Dystrophy Research
[…] 2017 – Today the FSH Society, a world leader in combating facioscapulohumeral muscular dystrophy ( FSHD), announced it has committed $541,133 in funding to five research projects that aim to […]
DUX4 vs. PAX7–Who’s the fairest one of all?
[…] years, DUX4 has enjoyed center stage in the yet-unfolding story of facioscapulohumeral muscular dystrophy ( FSHD). DUX4 was first identified in 19991, but only in the past five to 10 […]